RE:Best line of the release!Sometimes the market gets it all wrong. Case in point, XEBEC announced a min. $51M (3 year) contract with Sapio on mid May 2018. The stock was in mid 60's (?) or so, and the market cap of the company was about $50M. The share price had a jump, but languished for the rest of the year. That was a game changing contract that was unrecognized. As the story progressed, the share reacted, the share price is now over $5.
I could be totally wrong here, but the odds are stacked in our favor. News like today brings us some much closer to where we will be, a commercial PGX deal, whether pharma related or food, or...
captwade wrote: ......".establishing the feedstock for mass production of PGX-YBG, optimizing the process for large scale industrial manufacturing of PGX-YBG". This will mean big dollars as the margins should reflect the fact that Ceapro is the only company that can accomplish this.
This is a big day, and yet here we sit with 8 trades to this point in the day. Amazing.